Both in Pharmaceuticals
Aurinia Pharmaceuticals vs PERRIGO
Over the past year AUPH returned +29.4% and PRGO returned −20.2%; their daily moves had a correlation of 0.07.
AUPH +29.4% PRGO −20.2%Growth of $1, one year, split-adjusted
| Metric | AUPH | PRGO |
|---|---|---|
| Price | $16.56 | $15.70 |
| Market cap | $2.22B | $2.18B |
| Today | +2.60% | −0.32% |
| 1 month | +5.3% | +8.7% |
| 6 months | +3.2% | +34.9% |
| Year to date | +3.8% | +12.8% |
| 1 year | +25.7% | −24.3% |
| Revenue growth (YoY) | +13.9% | −3.2% |
| Gross margin | 90.1% | 30.7% |
| Net margin | 37.9% | 7.3% |
| P/E (TTM) | 7.1× | — |
| Price / sales | 6.9× | 0.5× |
| Net cash | $431.7M | -$2.90B |
| Dividend yield | — | 7.39% |
| Volatility (60d) | 30.3% | 40.2% |
| Short % of float | 7.3% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).